Forty Seven is an immuno-oncology company, which develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities.
|HQ||Menlo Park, US||Map|
Revenue (FY, 2019)
Net income (FY, 2019)
EBIT (FY, 2019)
When was Forty Seven founded?
Forty Seven was founded in 2014.
Who are Forty Seven key executives?
Forty Seven's key executives are Mark McCamish, Chris H. Takimoto and Ann D. Rhoads.
How many employees does Forty Seven have?
Forty Seven has 62 employees.
What is Forty Seven revenue?
Latest Forty Seven annual revenue is $15.7 m.
What is Forty Seven revenue per employee?
Latest Forty Seven revenue per employee is $252.9 k.
Who are Forty Seven competitors?
Competitors of Forty Seven include Immunicom, JW Therapeutics and Advanced Cancer Therapeutics.
Where is Forty Seven headquarters?
Forty Seven headquarters is located at 1490 O'Brien Dr, Menlo Park.
Where are Forty Seven offices?
Forty Seven has offices in Menlo Park, Mountain View and Sacramento.
How many offices does Forty Seven have?
Forty Seven has 3 offices.
Receive alerts for 300+ data fields across thousands of companies